
### [MONDO:0019950](http://purl.obolibrary.org/obo/MONDO_0019950)
**Label:** congenital muscular dystrophy

**Subclasses:** [MONDO:0011271](http://purl.obolibrary.org/obo/MONDO_0011271) (rigid spine muscular dystrophy 1), [MONDO:0009681](http://purl.obolibrary.org/obo/MONDO_0009681) (Ullrich congenital muscular dystrophy 1), [MONDO:0018279](http://purl.obolibrary.org/obo/MONDO_0018279) (congenital muscular dystrophy without intellectual disability), [MONDO:0014141](http://purl.obolibrary.org/obo/MONDO_0014141) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14), [MONDO:0009364](http://purl.obolibrary.org/obo/MONDO_0009364) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0018277](http://purl.obolibrary.org/obo/MONDO_0018277) (congenital muscular dystrophy with cerebellar involvement), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0018132](http://purl.obolibrary.org/obo/MONDO_0018132) (congenital muscular alpha-dystroglycanopathy with brain and eye anomalies), [MONDO:0018276](http://purl.obolibrary.org/obo/MONDO_0018276) (muscular dystrophy-dystroglycanopathy), [MONDO:0013160](http://purl.obolibrary.org/obo/MONDO_0013160) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2), [MONDO:0008029](http://purl.obolibrary.org/obo/MONDO_0008029) (Bethlem myopathy), [MONDO:0000355](http://purl.obolibrary.org/obo/MONDO_0000355) (Ullrich congenital muscular dystrophy), [MONDO:0011688](http://purl.obolibrary.org/obo/MONDO_0011688) (muscular dystrophy-dystroglycanopathy type B5), [MONDO:0012138](http://purl.obolibrary.org/obo/MONDO_0012138) (muscular dystrophy-dystroglycanopathy type B6), [MONDO:0018939](http://purl.obolibrary.org/obo/MONDO_0018939) (muscle-eye-brain disease), [MONDO:0013159](http://purl.obolibrary.org/obo/MONDO_0013159) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1), 

**Corr. equiv. classes:** [OMIM:602771](http://purl.obolibrary.org/obo/OMIM_602771), [Orphanet:370959](http://www.orpha.net/ORDO/Orphanet_370959), [OMIM:606612](http://purl.obolibrary.org/obo/OMIM_606612), [OMIM:254090](http://purl.obolibrary.org/obo/OMIM_254090), [OMIM:158810](http://purl.obolibrary.org/obo/OMIM_158810), [OMIM:615351](http://purl.obolibrary.org/obo/OMIM_615351), [OMIM:613155](http://purl.obolibrary.org/obo/OMIM_613155), [OMIM:613156](http://purl.obolibrary.org/obo/OMIM_613156), [OMIM:616538](http://purl.obolibrary.org/obo/OMIM_616538), [OMIM:608840](http://purl.obolibrary.org/obo/OMIM_608840), [Orphanet:370980](http://www.orpha.net/ORDO/Orphanet_370980), [Orphanet:899](http://www.orpha.net/ORDO/Orphanet_899), [Orphanet:588](http://www.orpha.net/ORDO/Orphanet_588), [Orphanet:610](http://www.orpha.net/ORDO/Orphanet_610), [Orphanet:352687](http://www.orpha.net/ORDO/Orphanet_352687), [Orphanet:75840](http://www.orpha.net/ORDO/Orphanet_75840), [OMIM:236670](http://purl.obolibrary.org/obo/OMIM_236670), [Orphanet:370953](http://www.orpha.net/ORDO/Orphanet_370953), 

**Class expressions from DL-Learner:**

- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 77.78%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 77.78%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 75.45%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.45%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 75.45%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.45%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.45%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.45%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.45%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.45%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 75.00%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.00%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.00%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 75.00%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) 73.42%


